CN102302734B - Agent for treating insomnia - Google Patents

Agent for treating insomnia Download PDF

Info

Publication number
CN102302734B
CN102302734B CN 201110251910 CN201110251910A CN102302734B CN 102302734 B CN102302734 B CN 102302734B CN 201110251910 CN201110251910 CN 201110251910 CN 201110251910 A CN201110251910 A CN 201110251910A CN 102302734 B CN102302734 B CN 102302734B
Authority
CN
China
Prior art keywords
insomnia
agent
root
treatment
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201110251910
Other languages
Chinese (zh)
Other versions
CN102302734A (en
Inventor
高新华
吕淑霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wang Yanling
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110251910 priority Critical patent/CN102302734B/en
Publication of CN102302734A publication Critical patent/CN102302734A/en
Application granted granted Critical
Publication of CN102302734B publication Critical patent/CN102302734B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an agent for treating insomnia. The agent comprises the following raw material drugs: tatarinow sweetflag rhizome, wenchow turmeric root tuber, paris polyphylla smith, common gardenia fruit, rheum, thinleaf milkwort root, Chinese gentian, pinellia, barbed skullcap herb, Chinese thorowax root, common cnidium fruit and fungus growing on bamboo root. The agent provided by the present invention has reasonable formulation, definite therapeutic effect, and effectively treats the insomnia.

Description

A kind of medicament for the treatment of of insomnia patients
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament for the treatment of of insomnia patients.
Background technology
Insomnia refers to fall asleep and maybe can't keep sleep state, causes not having enough sleep.Claim again DIMS (DIMS), for a variety of causes causes that difficulty falling asleep, Depth of sleep or frequency are too short, early awakening and the length of one's sleep are not enough or of poor quality etc., the common reason that causes having a sleepless night mainly contains environment reason, individual factors, body reason, Nervous and Mental Factors, emotional factor etc.According to Traditional Chinese medical theory, the reason of insomnia is mainly the internal organs disorder, especially the YIN nourishing function of the warming YANG function of the heart and kidney can not coordination, deficiency of qi and blood, imbalance of YIN and YANG etc.
Summary of the invention
The medicament that the purpose of this invention is to provide a kind for the treatment of of insomnia patients.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of of insomnia patients, it is made by weight by following bulk drugs:
Figure BSA00000564647900011
Preferably, it is made by weight by following bulk drugs:
Figure BSA00000564647900012
Preferably, described medicament of the present invention is tablet, dispersible tablet, capsule or decoction.
The reasonable recipe of medicament of the present invention, curative effect is clear and definite, effectively treatment of insomnia patients.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Rhizoma Acori Graminei 15 grams, Radix Curcumae 30 grams, Rhizoma Paridis 15 grams, Fructus Gardeniae 10 grams, Radix Et Rhizoma Rhei 15 grams, Radix Polygalae 45 grams, Radix Gentianae 30 grams, the Rhizoma Pinelliae 10 grams, Herba Scutellariae Barbatae 10 grams, Radix Bupleuri 15 grams, Fructus Cnidii 50 grams and Caulis Bambusae In Taenia 30 grams, place 800 ml waters, 90 ℃ of lower reflux 2 hours, filter, obtain filtering residue and filtrate.Described filtrate is concentrated into 500 milliliters, and get final product.
Experimental example
About dividing the diagnostic criteria of insomnia in the insomnia of apoplexy due to endogenous wind non-organic and the Ministry of Public Health " new Chinese medicine guideline of clinical investigations ", spiritual and behavior disorder choose the patient according to World Health Organization (WHO).Patient's 40 examples, at minimum 18 years old of age, maximum 63 years old, the course of disease was the shortest 3 months, reaches 10 years most.The patient all shows as and does not have enough sleep 4 hours every day, and taking sleeping pill, to begin effective later stage gradually invalid.Generally performance is sleeping shallow, easily frightenedly easily wake up, poor, tired, the hypomnesis of spirit after waking up, have in addition affect self care ability, aggravation.
Choosing the decoction of preparation among the embodiment 1 treats.Every day 3 times, each 50 milliliters.7 days is 1 course for the treatment of, treats two courses for the treatment of.Inactive other drug during the treatment.
Diagnostic criteria
Criterion of therapeutical effect with reference to insomnia in " new Chinese medicine guideline of clinical investigations " is drafted.Recovery from illness: recover normal the length of one's sleep, or Nighttime sleep reaches more than 6 hours, sleep is dull, and is in high spirits after waking up; Produce effects: sleep is clearly better, and increases the length of one's sleep more than three hours, and Depth of sleep increases; Effectively: sx↓, but increased less than the length of one's sleep three hours; Invalid: insomnia is without obviously improving or increasing the weight of after the treatment.
Therapeutic outcome
Described 40 routine patients all meet the standard of recovery from illness after treatment.And do not observe obvious untoward reaction.
After this in 1 month, all the patient is followed up a case by regular visits to weekly, found that recurrence does not all appear in all patients.

Claims (3)

1. the medicament of a treatment of insomnia patients is characterized in that, it is to be made by weight by following bulk drugs:
Figure FSB00000882159500011
2. the medicament for the treatment of of insomnia patients according to claim 1 is characterized in that, it is to be made by weight by following bulk drugs:
3. the medicament for the treatment of of insomnia patients according to claim 1 and 2 is characterized in that, described medicament is tablet, capsule or decoction.
CN 201110251910 2011-08-30 2011-08-30 Agent for treating insomnia Expired - Fee Related CN102302734B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110251910 CN102302734B (en) 2011-08-30 2011-08-30 Agent for treating insomnia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110251910 CN102302734B (en) 2011-08-30 2011-08-30 Agent for treating insomnia

Publications (2)

Publication Number Publication Date
CN102302734A CN102302734A (en) 2012-01-04
CN102302734B true CN102302734B (en) 2013-01-16

Family

ID=45376716

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110251910 Expired - Fee Related CN102302734B (en) 2011-08-30 2011-08-30 Agent for treating insomnia

Country Status (1)

Country Link
CN (1) CN102302734B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1382473A (en) * 2002-05-21 2002-12-04 崔行善 Medicine for treating psychic diseases
CN1513519A (en) * 2003-06-04 2004-07-21 郑淑英 Heart quieting and orifice opening capsule and its preparation
CN101642540A (en) * 2009-06-14 2010-02-10 李承平 Chinese patent medicine for tranquilizing and allaying excitement

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1382473A (en) * 2002-05-21 2002-12-04 崔行善 Medicine for treating psychic diseases
CN1513519A (en) * 2003-06-04 2004-07-21 郑淑英 Heart quieting and orifice opening capsule and its preparation
CN101642540A (en) * 2009-06-14 2010-02-10 李承平 Chinese patent medicine for tranquilizing and allaying excitement

Also Published As

Publication number Publication date
CN102302734A (en) 2012-01-04

Similar Documents

Publication Publication Date Title
CN105412858A (en) Syrup and preparation method thereof
CN103251796B (en) Traditional Chinese medicine for treating insomnia
CN103211962B (en) Chinese medicinal composition for treating anhypnia
CN102908396B (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN102302734B (en) Agent for treating insomnia
CN102813719A (en) Traditional Chinese medicine capsule for treating anhypnia
CN104491588A (en) Health-care tea used for insomnia
CN102068545B (en) Chinese medicinal liquid for treating stomach diseases
CN102813824A (en) Medicament for treating gastropathy
CN102283972A (en) Pharmaceutical composition for treating rib fracture
CN107095977A (en) A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling
CN103893598A (en) Traditional Chinese medicine for treating insomnia
CN106618032A (en) Health care medicine pillow
CN103191326B (en) Medicine preparation for treating coronary heart diseases
CN105832885A (en) Traditional Chinese medicine composition for treating insomnia
CN102670875B (en) Traditional Chinese medicinal composition for treating gastric ulcer
CN104510784A (en) Insomnia treatment traditional Chinese medicine composition
CN103585367A (en) Chinese medicinal composition for tranquilizing by nourishing heart
CN103638494A (en) Traditional Chinese medicinal preparation for treating palpitation and preparation method of traditional Chinese medicinal preparation
CN106309970A (en) Medicament for treating insomnia
CN106266679A (en) A kind of medicine treating insomnia
CN101129538A (en) Medicament for treating pain of gastric cavity
CN106075016A (en) A kind of preparation method of the Chinese medicine composition for treating insomnia
CN107441263A (en) A kind of Chinese medicine composition of effectively treating cancer
CN107213327A (en) A kind of pharmaceutical composition and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG

Free format text: FORMER OWNER: GAO XINHUA

Effective date: 20130802

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130802

Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

Address before: 272051 Shandong province Jining city wear Zhuangji wearing No. 1 Shandong Road, Jining city mental hospital

Patentee before: Gao Xinhua

TR01 Transfer of patent right

Effective date of registration: 20170502

Address after: 075061, room 3, unit 54, 301 South Ming Street, Shiqiao West, Zhangjiakou, Hebei

Patentee after: Wang Yanling

Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

TR01 Transfer of patent right
CP02 Change in the address of a patent holder

Address after: 266700 Shandong city of Qingdao Province Pingdu liaolan Town Road No. 2.

Patentee after: Wang Yanling

Address before: 075061, room 3, unit 54, 301 South Ming Street, Shiqiao West, Zhangjiakou, Hebei

Patentee before: Wang Yanling

CP02 Change in the address of a patent holder
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130116

Termination date: 20170830

CF01 Termination of patent right due to non-payment of annual fee